Browse > Article
http://dx.doi.org/10.22722/KJPM.2019.27.2.111

Clinical Features Affecting Antipsychotic Prescription for Delirium Patients  

Kim, Jongwon (Keyo Hospital)
Kim, Min-Hyuk (Department of Psychiatry, Yonsei University Wonju College of Medicine)
Paik, Soo-Hyun (Keyo Hospital)
Publication Information
Korean Journal of Psychosomatic Medicine / v.27, no.2, 2019 , pp. 111-118 More about this Journal
Abstract
Objectives : The purpose of this study was to investigate the clinical characteristics of antipsychotic medication prescription for the symptom control in patients with delirium. Methods : One hundred and eighty-five patients referred to consultation-liaison psychiatric services for delirium due to general medical condition were included in this study. All subjects were divided into two groups (antipsychotics users vs. antipsychotics nonusers), and comparison analyses on their clinical characteristics were performed. Results : One hundred and twenty nine patients (66.5%) used antipsychotics for their delirium, and 56 patients (30.3%) did not use antipsychotics. The history of psychotropic medication was more frequently observed in antipsychotic users (5.4% vs. 18.6%, χ2=5.498, p=0.022). Especially, the history of benzodiazepine use was significantly high in antipsychotics users. The total score and sub-items of delirium rating scale-severity items except for the psychomotor retardation item showed higher scores in antipsychotic users than in nonusers (all p<0.05). The total score of the delirium rating scale-diagnosis items was higher in antipsychotic users than in the nonusers (p=0.010). Conclusions : Delirium patients with more severe delirium symptoms and with more history of benzodiazepine use were treated with antipsychotics more frequently than those without. These findings imply that benzodiazepine may not only exacerbate delirium but be associated with aggression or psychomotor agitation that need immediate intervention. Clinicians may need to pay attention not only these external symptoms but also to hypoactive symptoms that may lead to misdiagnosis and undertreatment.
Keywords
Delirium; Treatment; Antipsychotics; Delirium rating scale;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Park JS, Kim JJ, Park SJ, Kim SM, Park JY. Clinical course according to antipsychotics prescription pattern in delirium. Koean J Psychosomatic Med 2017;25:120-128.
2 Ozbolt LB, Paniagua MA, Kaiser RM. Atypical antipsychotics for the treatment of delirious elders. J Am Med Dir Assoc 2008;9:18-28.   DOI
3 Thom RP, Mock CK, Teslyar P. Delirium in hospitalized patients: risks and benefits of antipsychotics. Cleve Clin J Med 2017;84:616-622.   DOI
4 Neufeld KJ, Yue J, Robinson TN, Inouye SK, Needham DM. Antipsychotic medication for prevention and treatment of delirium in hospitalized adults: A systematic review and meta-analysis. J Am Geriatr Soc 2016;64:705-714.   DOI
5 Lim HK, Paik IH, Oh K, Lee CU, Lee C. Comparison of the clinical efficacy and safety between intramuscular olanzapine and intramuscular haloperidol injection in the treatment of delirium. Korean J Psychopharmacol 2007;18:423-428.
6 Han CS, Kim YK. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004;45:297-301.   DOI
7 Skrobik YK, Bergeron N, Dumont M, Gottfried SB. Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med 2004;30:444-449.   DOI
8 Devlin JW, Roberts RJ, Fong JJ. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 2010;38:419-427.   DOI
9 Lawlor PG, Bush SH. Delirium diagnosis, screening and management. Curr Opin in Support Palliat Care 2014;8:286.   DOI
10 Bush SH, Kanji S, Pereira JL. Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development. J Pain Symptom Manage 2014;48:231-248.   DOI
11 Hall WH, Ramachandran R, Narayan S, Jani AB, Vijayakumar S. An electronic application for rapidly calculating Charlson comorbidity score. BMC cancer 2004;4:94.   DOI
12 American Psychiarty Association. Diagnostic and Statistical Manual of Mental Disorders, Foruth Edition (DSM-IV) Washington. DC, USA: American Psychiatric Association;2004.
13 Laurila JV, Pitkala KH, Strandberg TE, Tilvis RS. Detection and documentation of dementia and delirium in acute geriatric wards. Gen Hosp Psychiatry 2004;26:31-35.   DOI
14 Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-829.   DOI
15 Austin SR, Wong Y-N, Uzzo RG, Beck JR, Egleston BL. Why summary comorbidity measures such as the Charlson comorbidity index and Elixhauser score work. Med Care 2015;53:e65.   DOI
16 Trzepacz PT, Baker RW, Greenhouse J. A symptom rating scale for delirium. Psychiatry Res 1988;23:89-97.   DOI
17 Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N. Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci 2001;13:229-242.   DOI
18 Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry 2010;67:255-262.   DOI
19 Kishi Y, Kato M, Okuyama T. Delirium: patient characteristics that predict a missed diagnosis at psychiatric consultation. Gen Hospital Psychiatry 2007;29:442-445.   DOI
20 Davis JM. Dose equivalence of the antipsychotic drugs. Catecholamines and Schizophrenia: Elsevier;1975. p.65-73.
21 Zaal IJ, Devlin JW, Hazelbag M. Benzodiazepine-associated delirium in critically ill adults. Intensive Care Med 2015;41:2130-2137.   DOI
22 Bush SH, Tierney S, Lawlor PG. Clinical assessment and management of delirium in the palliative care setting. Drugs 2017;77:1623-1643.   DOI
23 Maldonado JR. Delirium pathophysiology: An updated hypothesis of the etiology of acute brain failure. Int J Geriatr Psychiatry 2018;33:1428-1457.   DOI
24 Triozzi PL, Goldstein D, Laszlo J. Contributions of benzodiazepines to cancer therapy. Cancer Invest 1988;6:103-111.   DOI
25 Maldonado JR. Neuropathogenesis of delirium: review of current etiologic theories and common pathways. Am J Geriatr Psychiatry 2013;21:1190-1222.   DOI
26 Paton C. Benzodiazepines and disinhibition: a review. Psychiatric Bulletin 2002;26:460-462.   DOI
27 Mancuso CE, Tanzi MG, Gabay M. Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacotherapy: J Hum Pharmacol Drug Ther 2004;24:1177-1185.   DOI
28 Kumar A, Bakhla AK, Gupta S, Raju BM, Prasad A. Etiologic and Cognitive Differences in Hyperactive and Hypoactive Delirium. The Primary Care Companion for CNS Disorders 2015:17.
29 Van Velthuijsen EL, Zwakhalen SM, Mulder WJ, Verhey FR, Kempen GI. Detection and management of hyperactive and hypoactive delirium in older patients during hospitalization: a retrospective cohort study evaluating daily practice. Int J Geriatr Psychiatry 2018;33:1521-1529.   DOI
30 Kobayashi K, Takeuchi O, Suzuki M, Yamaguchi N. A retrospective study on delirium type. Psychiatry Clin Neurosci 1992;46:911-918.   DOI
31 Campbell N, Boustani MA, Ayub A. Pharmacological management of delirium in hospitalized adults-a systematic evidence review. J Gen Intern Med 2009;24:848-853.   DOI
32 Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. The Lancet 2014;383:911-922.   DOI
33 Sadock B, Ruiz P. Kaplan & Sadock's synopsis of psychiatry: behavioral sciences: Walters Kluwer; 2015. p.697-704.
34 Maldonado JR. Acute brain failure: pathophysiology, diagnosis, management, and sequelae of delirium. Crit Care Clin 2017;33:461-519.   DOI
35 Jones RN, Fong TG, Metzger E. Aging, brain disease, and reserve: implications for delirium. Am J Geriatr Psychiatry 2010;18:117-127.   DOI
36 National Institute for Clinical Excellence. Delirium: prevention, diagnosis and management. London: NICE 2010.